ImmuCell Corporation (ICCC) vs Telomir Pharmaceuticals, Inc. (TELO)
ImmuCell Corporation and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. ImmuCell Corporation and Telomir Pharmaceuticals, Inc. are of similar size ($90.6M and $83.2M). Telomir Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; ImmuCell Corporation trades at 117×. ImmuCell Corporation has the higher net margin (2.57% vs 0.00%) and the higher return on invested capital (7.84% vs 0.00%). Across the 13 metrics below, ImmuCell Corporation leads on 10 and Telomir Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ICCC | TELO | Biotechnology median |
|---|---|---|---|
| Gross margin | 40.32% | — | 65.16% |
| Operating margin | 12.60% | 0.00% | 0.00% |
| Net margin | 2.57% | 0.00% | 0.00% |
| Free cash flow margin | 13.79% | 0.00% | 0.00% |
| Return on equity | 2.57% | (1,885.50%) | (57.72%) |
| Return on assets | 1.69% | (1,678.31%) | (49.22%) |
| Return on invested capital | 7.84% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack